Montauk Metals Inc. (TSX-V: MTK) (the “
Company” or
“
Montauk”) is pleased to announce that it is been
advanced US$200,000 (the “
Loan Amount”) pursuant
to the loan and option agreement (the “
Loan
Agreement”) with Omni Bridgeway (Fund 5) Canada
Investments Ltd. (“
Omni”), as previously announced
in its news release on November 9, 2023. The Loan Amount was
advanced to the Company in connection with the execution of
promissory note by Montauk in favour of Omni (the
“
Note”).
Background
Montauk brought arbitration proceedings (the
“Arbitration”) against the Republic of Colombia
(“Colombia”) to enforce the Company’s rights to
compensation under the Canada-Colombia Free Trade Agreement (the
“FTA”), as previously described in its news
releases of March 27, 2018, February 25, 2019, February 10, 2020,
November 23, 2021, September 1, 2023, October 5, 2023 and November
9, 2023 and subject to certain conditions and approvals as noted
below.
Montauk contends that Colombia breached its
obligations owed to the Company, including specific obligations
under the FTA. The claims include Colombia’s refusal or failure to
compensate the Company for the losses with respect to the Company’s
Reina de Oro project incurred as a consequence of Colombia’s
prohibition of mining in the páramos (high altitude eco-systems).
On March 21, 2018, Montauk filed a Request for Arbitration against
the Republic of Colombia before the International Centre for
Settlement of Investment Disputes (“ICSID”).
The Arbitration is being conducted in two
phases. Phase One will determine whether the ICSID Tribunal
adjudicating Montauk’s claims (the “Tribunal”)
under the FTA has jurisdiction over this case and whether Colombia
has breached its obligations under the FTA and is liable for
compensation to the Company. Assuming that ICSID decides in favour
of Montauk in Phase 1 (the “Phase 1 Decision”),
Phase 2 of the arbitration (“Phase 2”) will
involve determining the quantum of damages awarded to Montauk to
compensate it for losses incurred.
The Company must make a payment of US$200,000 to
ICSID (the “ICSID Payment”) before a ruling on
Phase 1 is rendered. The Company has advanced the Loan Amount to
ICSID to satisfy the ICSID Payment and expects for this to result
in the issuance of a decision on jurisdiction and liability. The
ICSID payment was originally required to be paid on or before
November 9, 2023 (the “Payment Deadline”), however
the Company advised ICSID that the Agreements (as defined below)
were subject to the approval of shareholders at a meeting of
shareholders to be held on December 14, 2023 (the
“Meeting”), and accordingly ICSID indicated that
they would extend the Payment Deadline until after the shareholders
vote to approve the Agreements at the Meeting. Shareholders of the
Company approved the Agreements at the Meeting.
Litigation Funding
The Loan Agreement grants Omni the option,
exercisable in the sole discretion of Omni (the “Phase
2 Election”) to provide litigation funding to the Company
pursuant to an arbitration funding agreement (the
“AFA”, and together with the Loan Agreement, the
“Agreements”). The Company, Omni and Lenczner
Slaght LLP entered into the AFA, which, should Omni exercise the
Phase 2 Election, provides Montauk an initial funding amount of up
to US$2,325,000 (the “Non-Recourse Funding
Amount”) subject to certain conditions. The Non-Recourse
Funding Amount will be used to fund Phase 2 and may be increased in
certain circumstances as may be agreed upon between the Corporation
and Omni.
If Omni elects to provide the Non-Recourse
Funding Amount for Phase 2 and the enforcement of any award
obtained by the Company in the Arbitration, the Loan Amount and
interest shall be repaid through proceeds recovered in the
Arbitration (and in the event there are no proceeds recovered in
the Arbitration, such amount inclusive of such interest shall be
payable by the Company at the conclusion of the Arbitration).
Please see the Company’s press release issued on November 9, 2023
and management information circular dated November 9, 2023 for
further information on the Agreements.
Omni’s return on the Non-Recourse Funding Amount
(the “Omni Return”) will be limited solely to
recovery from the amount of money for which the Arbitration is
settled, or for which a final, non-appealable award is given in
favour of the Corporation (the “Litigation
Proceeds”). The Omni Return shall be an amount calculated
as the sum of (i) a multiple of the amounts actually incurred of
the Non-Recourse Litigation Funding Amount and (ii) a percentage of
the gross recovery proceeds, both calculated when the recovery
proceeds are received, as set out in the table below:
Months |
Multiple |
Percentage |
0-12 |
2.0x |
12% |
12-24 |
3.0x |
14% |
24+ |
3.5x |
16% |
|
|
|
For any resolution that occurs on or after
thirty-six (36) months from the date Omni makes a positive Phase 2
Election, Omni’s Return shall bear interest at the rate of twelve
percent (12%) per annum, accruing and compounding on a monthly
basis.
The Litigation Proceeds, if received, will be
disbursed in the following order of priority: (a) Omni shall be
reimbursed the Recourse Loan and the amounts actually incurred of
the Non-Recourse Funding Amount; (b) Omni shall be paid the Omni
Return and legal counsel shall be paid their legal fees; and (c)
the balance shall be paid to the Corporation.
In connection with the Loan Agreement, Note and
LFA, the Company has agreed to grant Omni a continuing first
priority security interest over any and all assets of the Company
(whether presently held or acquired after the date hereof),
including the Company’s interest in any Litigation Proceeds.
The Company cannot guarantee that it will be
successful at the Arbitration, or that the estimated amounts
disclosed herein will not be revised as the Arbitration proceeds.
The Company also cannot guarantee that it will be able to recover
all or part of its legal and arbitration costs from Colombia even
if it is successful at the Arbitration. Management of the Company
will continue to provide updates on material developments of the
status of the Arbitration.
Private Placement
Withdrawal
Due to securing the foregoing funding, the
Company will not be proceeding with the proposed private placement
that was previously announced by the Company on October 5,
2023.
RISK DISCLOSURE STATEMENT: At
the present time, the Company’s payment obligations are
substantially in excess of its cash balances and it has no other
assets. The Company is not solvent and cannot continue as a going
concern. Trading in shares of the Company and any investment in the
Company is highly speculative. No trading in securities of the
Company or investment should be made without being able to lose the
entire amount of such funds. See below, “Cautionary Note Regarding
Forward-Looking Statements”. Investors are advised to seek
professional advice before making any decision to trade in or
invest in the securities of the Company.
Montauk Metals Inc.Mari DorenVP
Administration775-748-5221mdoren@montaukmetalsinc.com
www.galwaygoldinc.com
Cautionary Note Regarding
Forward-Looking Statements: This News Release includes
certain “forward-looking statements” which are not comprised of
historical facts. Forward-looking statements include estimates and
statements that describe Montauk’s future plans, objectives or
goals, including words to the effect that Montauk or management
expects a stated condition or result to occur. Forward-looking
statements may be identified by such terms as “believes”,
“anticipates”, “expects”, “estimates”, “may”, “could”, “would”,
“will”, or “plan”. Since forward-looking statements are based on
assumptions and address future events and conditions, by their very
nature they involve inherent risks and uncertainties. Although
these statements are based on information currently available to
Montauk, Montauk provides no assurance that actual results will
meet management’s expectations. Risks, uncertainties and other
factors involved with forward-looking information could cause
actual events, results, performance, prospects and opportunities to
differ materially from those expressed or implied by such
forward-looking information. Forward-looking information in this
news release includes, but is not limited to, the status of the
Arbitration, the merits and the associated costs of continuing the
Arbitration, the availability of funding for continuing the
Arbitration, the expected timelines for Arbitration decisions and
outcomes, and the Company’s ability to operate an active business
assuming an unfavourable result from the Arbitration. Factors that
could cause actual results to differ materially from such
forward-looking information include, but are not limited to: the
inability to reinstitute the Arbitration for any reason; costs of
the Arbitration for amounts which are in excess of anticipated
amounts; an inability on the part of the Company to succeed on
Phase One and Phase Two of the Arbitration and the resulting
failure to recover damages in respect of the termination of the
Reina de Oro project with a complete loss of all costs incurred in
respect of the Arbitration; any change in the legal landscape which
could render the Company’s pursuit of the Arbitration more or less
promising; any change in the legislation, policy and/or
jurisprudence of Colombia and/or Canada which could impact the
ability of the Company to recover damages in respect of the
termination of the Reina de Oro project; failure of Omni to
exercise the Phase 2 Election to provide litigation funding for
Phase 2; fluctuations in currency exchange rates diminishing the
ability to use of the proceeds of the litigation funding as
described; political risks; uncertainties relating to the
availability and costs of financing needed in the future; changes
in equity markets; inflation; changes in exchange rates;
fluctuations in commodity prices; assuming an unsuccessful result
at the Arbitration, the Company may have no commercial operations
and has no history of profit, while retaining significant
liabilities in connection with the Arbitration; risks of a material
adverse change to the Company’s ability to develop its properties
or generate revenue due to an unfavourable result at the
Arbitration; the ability to continue as a going concern assuming an
unfavourable result at the Arbitration; and those risks set out in
Montauk’s public documents filed on SEDAR+. Although Montauk has
attempted to identify important factors that could cause actual
actions, events, or results to differ materially from those
described in the forward-looking information, there may be other
factors that cause actions, events, or results not to be as
anticipated, estimated, or intended. There can be no assurance that
forward-looking information will prove to be accurate. The
forward-looking information contained herein is presented for the
purposes of assisting investors in understanding Montauk’s plans,
objectives, and goals and may not be appropriate for other
purposes. Accordingly, readers should not place undue reliance on
forward-looking information. Montauk does not undertake to update
any forward-looking information, except in accordance with
applicable securities laws.
Neither TSX Venture Exchange nor its Regulation
Services Provider (as that term is defined in the policies of the
TSX Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
Montauk Metals (TSXV:MTK)
Historical Stock Chart
From Sep 2024 to Oct 2024
Montauk Metals (TSXV:MTK)
Historical Stock Chart
From Oct 2023 to Oct 2024